Transgrediens lesions in patients with pachyonychia congenita - 10/08/11
KaLynne Harris, MD, University of Utah Department of Dermatology, Salt Lake City, UT, United States; C. David Hansen, MD, University of Utah Department of Dermatology, Salt Lake City, UT, United States; Sancy Leachman, MD, PhD, University of Utah Department of Dermatology, Salt Lake City, UT, United States; Frances Smith Irwin McLean, PhD, Epithelial Genetics Group, Division of Molecular Medicine, University of Dundee, Dundee, United Kingdom; Jack Arbiser, MD, PhD, Department of Dermatology, Emory University School of Medicine, Atlanta Veterans Administration Medical Center, Atlanta, GA, United States; Peter Hull, MBBCh, PhD, Department of Dermatology, Royal University Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
El texto completo de este artículo está disponible en PDF.| Commercial support: None identified. |
Vol 64 - N° 2S1
P. AB84 - février 2011 Regresar al número
Artículo precedente
- Recessive dystrophic epidermolysis bullosa with squamous cell carcinoma
- Muir–Torre syndrome: Surgical management and cancer screening guidelines
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?